Package 0378-3458-23

{"route": ["NASAL"], "spl_id": "6e1e173a-2d01-4e67-8361-dd30604bc8aa", "openfda": {"unii": ["0L591QR10I", "O2GMZ0LF5W"], "rxcui": ["1797847"], "spl_set_id": ["7b5cc5a0-0d47-46b5-b5fb-eb9cc248ae9e"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (0378-3458-23)  / 120 SPRAY, METERED in 1 BOTTLE", "package_ndc": "0378-3458-23", "marketing_end_date": "20270228", "marketing_start_date": "20200414"}], "brand_name": "Azelastine Hydrochloride and Fluticasone Propionate", "product_id": "0378-3458_6e1e173a-2d01-4e67-8361-dd30604bc8aa", "dosage_form": "SPRAY, METERED", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "0378-3458", "generic_name": "Azelastine Hydrochloride and Fluticasone Propionate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azelastine Hydrochloride and Fluticasone Propionate", "active_ingredients": [{"name": "AZELASTINE HYDROCHLORIDE", "strength": "137 ug/1"}, {"name": "FLUTICASONE PROPIONATE", "strength": "50 ug/1"}], "application_number": "NDA202236", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270228", "marketing_start_date": "20200414"}